NCT00538174View on ClinicalTrials.gov

Phase I Multiple-Ascending Dose (Japan)

PHASE1CompletedINTERVENTIONAL

Enrollment

36

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

May 31, 2008

Study Completion Date

May 31, 2008

Conditions

Diabetes Mellitus, Type 2

Interventions

DRUG

Dapagliflozin

Tablets, Oral, once daily up, to 14 days

DRUG

placebo

Tablets, Oral, 0 mg, once daily, up to 14 days

Trial Locations (1)

5650853

Local Institution, Suita

Sponsors

Lead Sponsor

All Listed Sponsors

lead

AstraZeneca

INDUSTRY